OmniAsset
Get app

OmniAsset › Mutual funds › Tata India Pharma & Healthcare Fund

Tata India Pharma & Healthcare Fund

Sectoral / Thematic fund benchmarked to BSE Healthcare TRI. Every figure below is read from one dated snapshot; what the snapshot cannot prove is left out, never estimated.

Latest NAV2 Sep 202639.6889
CategorySectoral / Thematic
PlanDirect · Growth
Launched4 Dec 2015
Risk labelthe scheme's own riskometerVery High
Legal benchmarkSEBI Tier-1BSE Healthcare TRI
Expense ratiodirect plan, a year1.06%
AUM₹439 Cr
Growth of ₹10,000₹19,8422 Sep 2021 to 2 Sep 2026
₹20,054₹17,136₹14,218₹11,300₹8,382Sep 2021Nov 2022Mar 2024Jun 2025Sep 2026
₹19,842 (+14.7% a year) Tata India Pharma & Healthcare Fund

Performance (trailing, annualised)

1Y annualised11.81%
3Y annualised21.12%
5Y annualised14.69%
10Y annualised15.12%

Point-to-point from the fund's own published NAV; a period the history does not span is left out.

SIP returns

SIP 1Y (₹10,000 a month)invested ₹1,20,000 → worth ₹1,33,11620.79%
SIP 3Y (₹10,000 a month)invested ₹3,60,000 → worth ₹4,49,95115.03%
SIP 5Y (₹10,000 a month)invested ₹6,00,000 → worth ₹9,55,20418.66%

₹10,000 on the first of every month, valued at the latest NAV, as an annualised rate (XIRR).

Calendar years

Calendar 202120.88%
Calendar 2022-6.64%
Calendar 202338.59%
Calendar 202442.48%
Calendar 2025-3.47%

Rolling returns

Rolling 1Y · average500 windows since 29 Dec 201616.53%
Rolling 1Y · median8.79%
Rolling 1Y · worst window-16.31%
Rolling 1Y · best window71.42%
Rolling 1Y · windows positive70%
Rolling 3Y · average397 windows since 31 Dec 201818.14%
Rolling 3Y · median21.28%
Rolling 3Y · worst window-2.95%
Rolling 3Y · best window30.42%
Rolling 3Y · windows positive91%
Rolling 5Y · average294 windows since 29 Dec 202018.89%
Rolling 5Y · median16.85%
Rolling 5Y · worst window9.85%
Rolling 5Y · best window31.36%
Rolling 5Y · windows positive100%

Every window of that length in the published history, so one lucky start date cannot flatter the fund.

Risk

Volatility (3Y)13.26%
Downside deviation (3Y)9.15%
Maximum drawdown-16.81%

Management

Fund managerRajat Srivastava
Managing since16 Sep 2024

What it holds

SecurityWeight
Sun Pharmaceutical Industries Ltd8.6%
Divi's Laboratories Ltd6.4%
Healthcare Global Enterprises Ltd5.9%
Abbott India Ltd5.6%
Rainbow Childrens Medicare Ltd4.9%
Glaxosmithkline Pharmaceuticals Ltd4.7%
Cipla Ltd4.5%
Dr. Reddy's Laboratories Ltd4.2%
Max Healthcare Institute Ltd4.1%
Apollo Hospitals Enterprise Ltd3.9%
SectorWeight
Healthcare92.2%
Materials5.8%
Consumer Staples1.1%

Portfolio disclosed: 99.1% by weight.

Related

Source: the OmniAsset signed reference snapshot, as of 4 Sep 2026. Figures are deterministic; missing data is withheld, never estimated. See methodology and data sources. Not investment advice.

Research this fund and compare it — on your device.

Get OmniAsset on Google Play The mutual fund tracker